Jerusalem, Israel

Yael Rosen

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Yael Rosen

Introduction

Yael Rosen is a notable inventor based in Jerusalem, Israel, renowned for her innovative contributions to the field of medicine. With a strong focus on finding novel treatments, she has been instrumental in developing effective solutions for various health issues, particularly focusing on the treatment of pruritus.

Latest Patents

Yael Rosen holds three patents, showcasing her commitment to advancing medical treatment. Her latest patents revolve around methods of treating pruritus. These patents detail a unique approach involving the topical administration of detomidine, or a pharmaceutically acceptable salt thereof, to alleviate this condition in subjects. This innovative treatment holds significant promise for improving patient comfort and care.

Career Highlights

Throughout her career, Yael has made significant strides in her field. Her dedication to research and her ability to translate complex scientific concepts into practical applications have made her a prominent figure in medical innovation. By actively working at Clexio Biosciences Ltd., she continues to push the boundaries of what is possible in therapeutic development.

Collaborations

Yael Rosen collaborates with a talented team, including her colleagues David Dangoor and Richard Fisher. Together, they work towards creating impactful solutions that address critical health challenges. Their collective expertise and commitment to innovation foster a creative environment that leads to groundbreaking research and patenting strategies.

Conclusion

In summary, Yael Rosen exemplifies the spirit of innovation in the medical field through her extensive work and patented inventions. Her efforts in establishing effective treatments for pruritus reflect her dedication to improving patient care. As she continues to contribute to Clexio Biosciences Ltd., her work is likely to inspire future advancements in medical sciences.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…